HAMDT 23 | ChamberLight

AMENDS

AMENDMENT PROGRESS

STEP 3 OF 3

Proposed

Considered

Disposed

Proposed
Considered
Disposed

DISPOSITION

ADOPTED

JUN 4, 2025

“On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.”

what this changes

This amendment requires the Department of Health and Human Services (HHS) to use general language when referring to opioid overdose reversal drugs in their official documents, rather than using specific brand names. This ensures that all medications approved by the FDA are treated equally in government guidance.

WHY IT MATTERS

Using generic language prevents the government from appearing to endorse one specific pharmaceutical brand over another. It also ensures that healthcare providers are encouraged to consider all safe, FDA-approved options for saving lives during an overdose.

WHO IS AFFECTED

This primarily affects government officials who write health policy and healthcare providers who look to federal guidance for treatment standards.

AMENDS

HR 2483BECAME LAW

SUPPORT for Patients and Communities Reauthorization Act of 2025

OTHER AMENDMENTS TO THIS BILL

KEY POINTS

low

Generic Language Requirement

Prevents the government from favoring specific drug brands like Narcan over other effective, approved alternatives.

low

Inclusion of Future Treatments

By using inclusive language, new medications approved by the FDA in the future will automatically be covered by existing guidance without needing manual updates.

low

Regulatory Consistency

Ensures all HHS documents use the same standards when discussing life-saving overdose medications.

GLOSSARY

HHS: The Department of Health and Human Services, the primary federal agency responsible for public health and social services.
Opioid Overdose Reversal Drugs: Medications designed to rapidly reverse the effects of an opioid overdose and restore normal breathing.

Official sources

HAMDT 23 on Congress.gov

This analysis used: Amendment description · Amended bill: status · Latest action

ACTION TIMELINE

4 EVENTS

JUN 4, 25

On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.

FLOOR

JUN 4, 25

Amendment (A001) offered by Mr. Bresnahan. (consideration: CR H2453; text: CR H2453)

FLOOR

JUN 4, 25

House Amendment Offered

FLOOR

JUN 4, 25

House amendment agreed to: On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.

FLOOR

READER REACTIONS

0 COMMENTS

WHAT DO YOU THINK?

What do you think?

0 votes

Discussion

Loading comments...

An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.

AMENDS

SUMMARY

KEY POINTS

SPONSORSHIP

ACTION TIMELINE

AMENDMENT INFO

READER REACTIONS

Discussion

An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.

AMENDS

AMENDMENT PROGRESS

DISPOSITION

WHY IT MATTERS

WHO IS AFFECTED

KEY POINTS

GLOSSARY

Official sources

ACTION TIMELINE

SPONSORS

READER REACTIONS

What do you think?

Discussion

Search

An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.

AMENDS

SUMMARY

KEY POINTS

SPONSORSHIP

ACTION TIMELINE

AMENDMENT INFO

READER REACTIONS

Discussion

An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.

AMENDS

AMENDMENT PROGRESS

DISPOSITION

WHY IT MATTERS

WHO IS AFFECTED

KEY POINTS

GLOSSARY

Official sources

ACTION TIMELINE

SPONSORS

READER REACTIONS

What do you think?

Discussion